FOXO3

In one line: FOXO3 is a master switch inside your cells — held idle when growth signals run high, but released into the nucleus under stress to turn on antioxidant defense, DNA repair, and cellular recycling; one version of it keeps turning up in the people who live to 100.

---

The gene

FOXO3 (forkhead box O3) sits on the long arm of chromosome 6, at 6q21. It doesn't build a structural part or an enzyme that does one job — it's a transcription factor, a master switch that binds DNA and turns whole sets of other genes on at once. The set it controls is the cell's threat-response program. Apart from APOE (the gene best known for Alzheimer's risk), FOXO3 is the most consistently replicated genetic association with human longevity ever found — the two genes the CHARGE GWAS meta-analysis singled out across populations.

The hunt

The longevity link didn't start with old people — it started with a worm. In 1993, Cynthia Kenyon's lab showed that changing a single gene (daf-2) let C. elegans live more than twice as long as normal — but only if a second gene, daf-16, was intact. daf-16 turned out to be the worm's single copy of the FOXO family of forkhead transcription factors (mammals later split that one ancestral gene into four: FOXO1/3/4/6). The worm had handed us the pathway. Then in 2008, Bradley Willcox and colleagues, studying long-lived men of Japanese ancestry in Hawaii, found a version of FOXO3 carried by those who reached the greatest ages: one protective copy nearly doubled the odds of living into the mid-90s, two copies nearly tripled them. It replicated in German, Italian, Chinese, and other cohorts worldwide.

The mechanism

FOXO3 is governed by where it sits in the cell. When food is plentiful and growth signals — insulin and IGF-1 — run high, the PI3K→AKT pathway phosphorylates FOXO3; a 14-3-3 protein then binds it and holds it out in the cytoplasm, idle. When the cell is stressed — oxidative damage, nutrient scarcity — that brake comes off and FOXO3 moves into the nucleus, where it switches on the defense program: antioxidant enzymes (SOD2/MnSOD, catalase) that neutralize reactive oxygen species, DNA-repair genes (e.g. GADD45), and autophagy — the machinery that digests and recycles a cell's own damaged parts. Defend, repair, clean house.

The stakes, and the frontier

This is why the longevity variant matters: it isn't a gene for immortality, it's a gene for cells that defend themselves better, for longer. Carriers of the FOXO3 longevity genotype show lower coronary-heart-disease mortality and reduced rates of other aging-related disease — healthspan, not just lifespan. There is no FOXO3 drug. But the pathway it sits on is the very one that fasting, exercise, and caloric restriction push on: dial the insulin/IGF growth signal down, and FOXO3 is freed to work. The open question is whether we can hand everyone the protection that a lucky few simply inherit.

Sources

Full claim-by-claim evidence is in references.md. Primary anchors:

• Kenyon et al. 1993, Nature 366:461 — C. elegans daf-2 mutant lives twice as long; requires daf-16.
• Willcox et al. 2008, PNAS 105:13987 — FOXO3 genotype strongly associated with human longevity.
• Flachsbart et al. 2009, PNAS 106:2700 — replication in German centenarians.
• Broer et al. 2015 (CHARGE), J Gerontol A 70:110 — GWAS confirms APOE and FOXO3 candidacy.
• Brunet et al. 1999, Cell 96:857 — AKT phosphorylation governs FOXO cytoplasmic retention.
• Kops et al. 2002, Nature 419:316 / Tran et al. 2002, Science 296:530 — FOXO3 drives antioxidant (MnSOD) and DNA-repair (GADD45) programs.

Accuracy note (the traps the fact-gate caught): (1) daf-16 is the worm's single, ancestral FOXO gene — not "FOXO3 specifically"; the episode says "the FOXO family FOXO3 belongs to." (2) The longevity SNP (rs2802292) is a regulatory/non-coding variant that changes how much FOXO3 is expressed — it does not break the protein — so the episode says "version/variant," never "mutant," and frames longevity as an association, not a guarantee. (3) The original 2008 association was found in men; later work extended it to women.